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Differential expression of the CD4 and CD8  antigens on T  lymphocytes has 
been used as a basis to construct models of thymic differentiation, and to identify 
functionally distinct subsets of T  cells (1, 2). In the thymus, most cells coexpress 
both  CD4  and  CD8,  while  minor  subpopulations  express  the  phenotypes 
CD4-,8-; CD4+,8-; and CD4-,8 + (1, 2). It has been proposed that during thymic 
ontogeny CD4-,8- precursor cells differentiate into CD4÷,8 + thymocytes. Upon 
maturation,  CD4+,8 + thymocytes acquire the CD3/Ti complex and presumably 
lose  either  CD4  or  CD8,  then  CD3÷,4+,8 -  and  CD3+,4-,8 +  T  lymphocytes 
migrate  into peripheral  tissues  (1,  2).  Mature  CD3+,4+,8 -  T  cells augment  Ig 
secretion  by B  lymphocytes and  facilitate the  generation  of cytotoxic T  cells, 
whereas  CD3+,4-,8 +  T  cells  predominately  mediate  cytotoxicity and  immune 
suppression (3, 4). In general, antigenic recognition by CD4 + T  cells is restricted 
by class II  MHC gene products,  whereas antigenic recognition by CD8 ÷ cells is 
restricted by class I  MHC antigens (5, 6). It has been generally accepted that all 
peripheral T  cells express either CD4 or CD8, with a minor population expressing 
both antigens. However, we have recently observed that a small subset of human 
peripheral  blood CD3 + T  lymphocytes express neither CD4  nor CD8.  Herein, 
we describe the characteristics of this unique subset of T  cells. 
Materials and  Methods 
Isolation of  Peripheral Blood CD3+,4-,8 - T Lymphocytes.  Mononuclear cells from normal 
peripheral  blood  (Stanford  Blood  Center,  Palo  Alto,  CA)  were  isolated  using  Fi- 
coll/Hypaque. Monocytes were depleted by plastic adherence. Nonadherent cells  were 
stained with a mixture of FITC-conjugated anti-Leu-2 (CD8),  FITC-conjugated anti-Leu- 
3 (CD4), and phycoerythrin (PE)-conjugated anti-Leu-4 (CD3) (7). After extensive washing 
in  ice cold PBS,  the cells were resuspended in  PBS containing  1%  FCS.  Lymphocytes 
expressing CD3, but lacking both CD4 and CD8, would therefore show specific red (PE) 
fluorescence, but not green (FITC) fluorescence, CD3+,4-,8 - cells were isolated to >95% 
purity using a FACS 440 (Becton Dickinson lmmunocytometry Systems, Mountain View, 
CA)  (7).  Fluorochrome-conjugated, isotype-matched control  antibodies  were  used  to 
establish the specificity of antibody binding (7). 
Antibodies.  Anti-Leu-1, -Leu-2, -Leu-3, -Leu-4, -Leu-5, -Leu-6, -Leu-11, and -Leu-12 
react  with  the  CD5,  CD8,  CD4,  CD3,  CD2,  CD1,  CD16,  and  CD19  differentiation 
antigens,  respectively. Anti-Leu-19  reacts with  the  Leu-19  (NKH-1) antigen,  which  is 
present on NK cells and a subset of T  lymphocytes (8). 
lmmunofluorescence and Flow Cytometry.  Methods of immunofluorescence, flow cytom- 
etry, and data analysis  have been presented elsewhere (7, 9). 
Cytotoxicity  Assays.  5~Cr-labeled tumor cells were used as targets in a 4-h radioisotope 
release assay (7). 
Cell  Culture.  Cells  were cultured in  RPMI  1640 supplemented with  10%  FCS (KC 
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FIGURE  1.  CD3 ÷ T  cells expressing neither CD4  nor CD8.  (A) Lymphocytes were stained 
with FITC-IgG and PE-IgG control antibodies (left) or PE anti-Leu-4 (CD3) and a mixture of 
F1TC anti-Leu-3 (CD4) and FITC anti-Leu-2 (CDS) (right). Based on the control sample, the 
contour plot was divided into quadrants representing unstained cells (lower left), cells with only 
red fluorescence (upper left),  cells with red and green fuorescence (upper right),  and cells with 
only green fluorescence (lower right).  Lymphocytes expressing CD3, but lacking both CD4 and 
CD8  would  therefore  be present in  the  upper  left quadrant (i.e.,  red is positive,  green  is 
negative).  In  this individual, 79.8%  of lymphocytes expressed the CD3  antigen, and 8.5% 
were CD3+,4-,8 -.  In the Ig isotype-matched control sample, <0.01%  of lymphocytes were 
present in the upper left quadrant and >98% were unstained (lower left quadrant), a, anti. (B) 
In  vitro  cultured  CD3÷,4-,8 -  lymphocytes  were  stained  as  described  in  (A).  90%  of  the 
lymphocytes were CD3+4-,8 -. Note that 10% of the lymphocytes were stained both red (CD3 +) 
and dim green (upper left).  Immunofluorescent staining with only FITC anti-Leu-2 and  PE 
anti-Leu-4 gave an identical profile, indicating that these cells were CD3+,CD8 a~=+ (not shown). 
No CD4 + lymphocytes were detected in these cultures, a, anti. 
Biologicals, Lexena, KS), 1 mM glutamine,  100 #g/ml gentamicin,  and 1000 U/ml rlL-2 
(Cetus Corp., Emeryville, CA). 
Results and Discussion 
Peripheral blood lymphocytes from normal donors were stained with PE anti- 
Leu-4  (CD3)  and  a  mxiture  of FITC  anti-Leu-2  (CD8)  and  FITC  anti-Leu-3 
(CD4) and  were analyzed by flow cytometry. A  small subset of cells expressed 
CD3 antigen (a component of the T  cell antigen receptor), but lacked both CD4 
and CD8 (Fig.  1). Based on analysis of >20 normal blood donors, ~3% of blood 
lymphocytes comprised  CD3+,4-,8 -  T  lymphocytes (range,  <0.5-23%)  (~78% 
of lymphocytes were CD3+).  The  specificity of the  staining  was confirmed  by 
showing  that  an  identical  percentage  of lymphocytes  was  observed  using  a 
reciprocal set of reagents (i.e.,  FITC anti-Leu-4 and a mixture of PE anti-Leu-2 
and PE anti-Leu-3), and by direct three-color immunofluorescence analysis using 
FITC  anti-Leu-2,  PE anti-Leu-3,  and  APC anti-Leu-4  (not shown). 1 By three- 
color immunofluorescence, 2 we also determined  that  >90%  of the CD3+,4-,8 - 
Identical results have also been obtained using the T3, T4 and T8 mAbs (Coulter Immunology, 
Hialeah, FL). 
This  was  determined  by  three-color immunofluorescence by staining lymphocytes  with APC 
streptavidin/biotin anti-Leu-4 (CD3),  a  mixture of PE anti-Leu-2 and PE anti-Leu-3, and a  third 
FITC-conjugated antibody (e.g.,  FITC anti-Leu-1  [CD5],  FITC anti-Leu-5 [CD2 l, etc.).  By gating 
on  CD3+,4-,8 -  (APC+,PE--stained)  lymphocytes,  it  was  possible  to  determine  the  proportion  of 
CD3+,4-,8 - cells that expressed the antigen detected by the F1TC-conjugated antibody. LANIER ET  AL.  BRIEF  DEFINITIVE REPORT  34! 
cells coexpressed the  CD2  and  CD5  pan  T  cell antigens,  but  did not express 
antigens associated with B cells (CD 19), N K cells (CD 16), thymocytes (CD 1), or 
monocytes (Leu-M3). 
CD3÷,4-,8 - iymphocytes were isolated to >90% purity using a FACS. 105 cells 
were placed into culture in medium containing rIL-2. After 2 wk, -5 ×  106 cells 
were recovered and reanalyzed for expression of CD4 and CD8. >99%  of the 
rIL-2-cultured  lymphocytes expressed  CD3,  and  90%  were  CD3+,4-,8 -  (Fig. 
1B). We failed to detect any cells (<0.5%) that expressed either CD4 or CD16. 
These  results  clearly  show  that  CD3+,4-,8 -  T  lymphocytes can  proliferate  in 
response  to  rIL-2  without  deliberate  antigenic  stimulation  and  that  the 
CD3+,4-,8 -  phenotype  is  stably  maintained.  It  should  be noted  however that 
10%  of  the  rIL-2-cuitured  CD3 +  T  cells  did  express  CD8  antigen,  but  in 
approximately  one-tenth  of the  amount  present  on  typical  blood CD3+,8 + T 
lymphocytes. Lymphocytes expressing "dim" CD8 have been described; however, 
in  these prior  reports  most CD8  dim+ cells lacked CD3 and  were CD3-,  CD16 + 
NK cells (7).  Whether  CD3+,CD4-,CD8 dim+ lymphocytes were generated  from 
the CD3÷,4-,8 -  population or were a contaminant  in the isolation procedure is 
unknown. 
Morphological examination  revealed that >80% of CD3+,4-,8 -  cells cultured 
only  in  rIL-2  were  large  lymphoblasts  with  abundant  cytoplasm  containing 
predominant azurophilic granules (Fig. 2 A). In contrast, >90 % of freshly isolated 
CD3+,4-,8 -  cells were agranular  lymphocytes, although  a  small  proportion  of 
granular  cells was observed in some donors (Fig.  2B). Since both NK cells and 
some  CTL  possess  this  characteristic  granular  morphology,  these  cells  were 
tested for cytotoxic activity. CD3+,4-,8 - T  cells cultured only in rIL-2 lysed NK- 
sensitive  K562  and  NK-insensitive JY  targets  (Fig.  3A).  Since  K562  lacks cell 
surface expression of both class I and II MHC antigens,  these results show that 
rIL-2-cultured CD3+,4-,8 -  T  lymphocytes recognize and lyse tumor cell targets 
without MHC restriction.  Freshly isolated CD3+,4-,8 -  T  cells did not lyse K562 
(Fig.  3B).  The  rIL-2-activated  CD3+,4-,8 -  cells  could  be  distinguished  from 
freshly isolated CD3+,4-,8 -  cells based on expression of Leu-19 antigen.  >70% 
of rIL-2-stimulated CD3+,4-,8 - cells expressed Leu- 19, whereas generally <10% 
of freshly isolated CD3+,4-,8 -  cells expressed Leu-19. Recently, we have shown 
that  the  Leu-19 antigen  is expressed on  essentially all  peripheral  blood CD3- 
NK cells, but is also present on a small subset of freshly isolated peripheral blood 
CD3 + T  lymphocytes  (most  of which  express  CD8)  that  mediate  non-MHC- 
restricted cytotoxicity (8). 
The cytotoxicity mediated by rIL-2-cultured CD3+,4-,8 -  lymphocytes against 
K562 was significantly augmented by the presence of soluble anti-Leu-4 antibody 
in the cytotoxicity assay (Fig. 4). Although anti-CD3 antibodies generally inhibit 
the cytotoxic function of antigen-specific CTL activity against the specific target 
antigen,  it  has  been  observed  that  anti-CD3  antibodies  actually  induce  non- 
specific  iyse of inappropriate  targets  (10).  The  finding  that  anti-CD3  induces, 
rather  than  inhibits,  the  cytotoxicity of the  rIL-2-activated  CD3+,4-,8 -  cells 
suggests  that  this  population  may be  polyclonal,  containing  cytotoxic cells  of 
several specificities which are triggered in the presence of anti-CD3. 
These  results  are  compatible  with  the  hypothesis  that  the  peripheral  blood 
CD3+,4-,8 -  population is polyclonal, and that a  Leu-19  + cytotoxic subset within 342  LANIER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
FIGURE 2.  Morphology of CD3÷,4-,8  - T  lymphocytes. Cells were cytocentrifuged onto glass 
slides and stained with Giemsa. (A) rlL-2-cultured CD3+,4-,8  - lymphocytes; (B) freshly isolated 
peripheral blood CD3+,4-,8  - lymphocytes. Magnification, × 6,000. 
the CD3+,4-,8 -  population can proliferate directly in response to rlL-2, without 
deliberate antigenic stimulation.  Further  studies  on  the precursors  of the  cyto- 
toxic cells within the CD3+,4-,8 -  subset will be necessary to identify the frequency 
and phenotype of these cells, and investigate their relationship to the lymphokine- 
activated killer phenomenon. 
The  existence  of  CD3+,4-,8 -  T  lymphocytes  shows  that  a  minor  subset  of LANIER  ET  AL.  BRIEF  DEFINITIVE  REPORT  343 
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FIGURE  3.  Cytotoxicity  mediated  by  CD4-,8-  T  lymphocytes  (A)  An  rlL-2-culturefl 
CD3+,4-,8 - cell line shown in Fig. 1  B, was assayed for cytotoxicity against K562 (closed symbols) 
and JY (open symbols). (B)  Lymphocytes were stained with PE anti-Leu-1  and a  mixture of 
FITC anti-Leu-2, FITC anti-Leu-3, and FITC anti-Leu-12. Lymphocytes that showed exclu- 
sively red  immunofiuorescence (i.e.,  CD5+,4-,8-,12 -) were  isolated with a  FACS  to >95% 
purity.  These  freshly isolated CD5+,4-,8 -  T  lymphocytes (O)  were assayed for cytotoxicity 
against K562.  In  these experiments, T  cells were identified with an antibody against CD5 
rather than CD3,  since antibodies against CD3  have been shown to either induce or inhibit 
cytotoxic  function  (10).  >95%  of  the  CD5+,4-,8-,12 -  lymphocytes  coexpressed  CD3,  as 
determined by three-color immunofluorescence analysis. FITC anti-Leu-12 (CD19, pan B cell 
antigen) was used to exclude any CD5  + B lymphocytes from the T  lymphocyte population. As 
a  positive control, NK cells (A),  i.e., the CD5-,4-,8-,19-  population, were isolated from the 
same individual's blood and assayed for cytotoxicity. 
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FIGURE 4.  Effect ofanti-CD3 on cytotoxicity, rlL-2-cultured CD3÷,4-,8 - cells were assayed 
for cytotoxicity against K562 in the presence (O) or absence (O) of soluble anti-Leu-4 antibody 
(final concentration 2 #g/ml) in the 4 h radioisotope release assay, a, anti; abscissa, E/T ratio. 
functionally  competent  peripheral  T  cells  apparently  does  not  require  either 
CD4 or CD8 expression.  Furthermore,  these studies raise questions regarding 
the origin of these unique T  cells. Recently, De La Hera et al. (11) have reported 
that in vitro culture of CD3+,4-,8 -  thymocytes in IL-2 results in the generation 
of non-MHC-restricted cytotoxic cells. It seems likely that these thymocytes are 
the  immediate  precursor  for  the  CD3+,4-,8 -  T  lymphocytes  that  we  have 
detected in peripheral blood. 
Summary 
CD3 + T  lymphocytes expressing neither CD4 nor CD8 antigens exist in normal 
human  peripheral  blood  in  low  frequency  (~3%  of  lymphocytes).  The 
CD3+,4-,8 -  phenotype  was  stably  maintained  after  in  vitro  culture  in  IL-2. 
Culture of CD3+,4-,8 -  cells in only rlL-2 generated cytotoxic T  cells that lysed 
NK-sensitive  and  NK-insensitive  tumor  cell  targets  without  MHC  restriction. 
These experiments clearly show that phenotypically and functionally competent 
T  cells expressing neither CD4 nor CD8 are present in normal peripheral blood. 344  LANIER  ET  AL.  BRIEF  DEFINITIVE REPORT 
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